Director, Integrative Oncology Sciences & Biomarker Innovation
GlaxoSmithKline plc
Consigue una respuesta de este empleador
Tu currículum y tu carta de presentación, adaptados exactamente a lo que buscan contratar.
Ventajas ofrecidas por este puesto de trabajo
Descripción de la vacante
GSK seeks a visionary Director, Integrative Sciences to lead diagnostic innovation in oncology, leveraging AI/ML, multi-modal omics, and translational biomarker strategies. You will shape biomarker, diagnostic, and clinical development programs, especially for ADCs, and guide analyses of trial biomarker data to enable translational medicine.
Based at Cambridge, MA with plans to relocate offices to Cambridge, UK, the role offers a hybrid work model and a competitive package including annual
Formación
- PhD in computational biology, bioinformatics, or related field.
- 7+ years in pharma/biotech with oncology biomarker focus.
- Proven cross-functional leadership in matrix environments.
- Experience with diagnostic platforms and translational medicine.
- Strong statistical and data analysis skills.
Responsabilidades
- Lead innovation in diagnostic tech, including AI/ML approaches.
- Develop oncology foundational models for complex datasets.
- Apply biomarkers to optimize patient selection and dosing strategies.
- Oversee integration of models to inform translational medicine.
- Collaborate with CPMS, Diagnostics, and AI/ML teams for insights.
- Evaluate new tech platforms to advance diagnostic innovation.
Conocimientos
Educación
Herramientas
Descripción del empleo
GSK seeks a visionary Director, Integrative Sciences to lead diagnostic innovation in oncology, leveraging AI/ML, multi-modal omics, and translational biomarker strategies. You will shape biomarker, diagnostic, and clinical development programs, especially for ADCs, and guide analyses of trial biomarker data to enable translational medicine.
Based at Cambridge, MA with plans to relocate offices to Cambridge, UK, the role offers a hybrid work model and a competitive package including annual
'/%3e%3cpath%20d='M101.744%2012.4726L102.894%2016.1947L99.0021%2013.2201L101.744%2012.4726ZM105.3%208.40937H100.488L99.0026%203.59473L97.5116%208.41047L92.7%208.40385L96.5965%2011.3834L95.1055%2016.1942L99.0021%2013.2196L101.408%2011.3834L105.3%208.40992V8.40937Z'%20fill='white'/%3e%3cdefs%3e%3clinearGradient%20id='paint0_linear_5593_1381'%20x1='90'%20y1='9.44471'%20x2='99'%20y2='9.44471'%20gradientUnits='userSpaceOnUse'%3e%3cstop%20stop-color='%2300AD70'/%3e%3cstop%20offset='0.998594'%20stop-color='%2300B67A'/%3e%3cstop%20offset='1'%20stop-color='%23DCDCE6'/%3e%3c/linearGradient%3e%3c/defs%3e%3c/svg%3e){kind=small}
